CIK 0001810182
- Non-accelerated filer
- Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 850642577
- Phone
- +1 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-26 | Shantharam Harish Chief Financial Officer | Grant or award · Stock option (right to buy) | +303,000 | 303,000 | ||
| 2025-10-14 | Shantharam Harish Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +198,750 | 198,750 | ||
| 2025-08-18 | Shantharam Harish Chief Financial Officer | Purchase | +75,000 | $0.78 | $58K | 75,000 |
| 2025-04-11 | Shantharam Harish Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2025-01-21 | Shantharam Harish Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +600,000 | 600,000 |
Page 1 of 1 · 5 trades